Results 101 to 110 of about 29,631 (205)

Optic neuritis secondary to the Pfizer-BioNTech-162b2 COVID-19 vaccine managed with plasmapheresis: A case report and review

Oman Journal of Ophthalmology, 2022
Paras P Shah, Samuel Gelnick, Daniel Zhu, Amanda Wong, Rashmi Verma   +4 more
doaj   +1 more source

The Efficacy of COVID‐19 Vaccination in Mortality Among Multi‐Ethnic Long‐Term Care Residents in New Zealand

Australasian Journal on Ageing, Volume 45, Issue 2, June 2026.
ABSTRACT Objective Older adults faced heightened vulnerability during the COVID‐19 pandemic, leading to increased mortality. This study investigated the impact of COVID‐19 vaccination on COVID‐19‐related mortality among the main ethnic groups in long‐term care during the Delta‐Omicron wave in New Zealand.
Gary Cheung, Tony Wu, Kebede Beyene, Amy Hai Yan Chan, Hamish Jamieson, Mataroria Lyndon, Joanna Hikaka, Etuini Ma'u, Brigette Meehan, Xaviour Walker, Claudia Rivera‐Rodriguez   +10 more
wiley   +1 more source

Cardiovascular Adverse Events Reported from COVID-19 Vaccines: A Study Based on WHO Database

International Journal of General Medicine, 2021
Rimple Jeet Kaur,1 Siddhartha Dutta,1 Jaykaran Charan,1 Pankaj Bhardwaj,2 Ankita Tandon,3 Dharamveer Yadav,4 Salequl Islam,5 Mainul Haque6 1Department of Pharmacology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India; 2Department of ...
Jeet Kaur R, Dutta S, Charan J, Bhardwaj P, Tandon A, Yadav D, Islam S, Haque M   +7 more
doaj  

SARS‐CoV‐2 Infection, Vaccination Status, and Dementia Risk: A Nested Case–Control Study

Influenza and Other Respiratory Viruses, Volume 20, Issue 6, June 2026.
ABSTRACT Objectives Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) may affect cognition, but its association with incident dementia remains inconsistent. We explored the association of SARS‐CoV‐2 infection and its vaccination with dementia risk in a nationwide sample of middle‐aged and older adults.
Nika Zur, Nili Stein, Walid Saliba, Galit Weinstein   +3 more
wiley   +1 more source

Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults

Scientific Reports, 2023
In this single-center observational study with 1,206 participants, we prospectively evaluated SARS-CoV-2-antibodies (anti-S RBD) and vaccine-related adverse drug reactions (ADR) after basic and booster immunization with BNT162b2- and ChAdOx1-S-vaccines ...
Simon Dedroogh, Sven Schmiedl, Petra A. Thürmann, Katharina Graf, Sebastian Appelbaum, Reinhard Koß, Christian Theis, Zewarudin Zia, Jürgen Tebbenjohanns, Serge C. Thal, Michael Dedroogh   +10 more
doaj   +1 more source

Autoimmune Hepatitis Following COVID‐19 Vaccination in a Patient With Ulcerative Colitis: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Autoimmune hepatitis (AIH) following COVID‐19 vaccination is a rare adverse event. We present the case of a 55‐year‐old male with a history of ulcerative colitis (UC) who developed AIH 3 weeks after receiving his second dose of the Pfizer–BioNTech mRNA vaccine. He presented with jaundice and significantly elevated liver enzymes. A liver biopsy
Marwah Algodi, Mohamed Nasser Elshabrawi, Mohamed Abuelazm, Ibrahim Gowaily, Omar Saab, Hatem Eltaly, Constantine Fisher   +6 more
wiley   +1 more source

Differences in B-Cell Immunophenotypes and Neutralizing Antibodies Against SARS-CoV-2 After Administration of BNT162b2 (Pfizer-BioNTech) Vaccine in Individuals with and without Prior COVID-19 - A Prospective Cohort Study

Journal of Inflammation Research, 2022
José Javier Morales-Núñez,1 Mariel García-Chagollán,1 José Francisco Muñoz-Valle,1 Saúl Alberto Díaz-Pérez,1 Paola Carolina Torres-Hernández,2 Saraí Citlalic Rodríguez-Reyes,3 Guillermo Santoscoy-Ascencio,4 José Julio Sierra García de Quevedo,4 Jorge ...
Morales-Núñez JJ, García-Chagollán M, Muñoz-Valle JF, Díaz-Pérez SA, Torres-Hernández PC, Rodríguez-Reyes SC, Santoscoy-Ascencio G, Sierra García de Quevedo JJ, Hernández-Bello J   +8 more
doaj  

Risk of thyroid dysfunction associated with mRNA and inactivated COVID-19 vaccines: a population-based study of 2.3 million vaccine recipients

BMC Medicine, 2022
Background In view of accumulating case reports of thyroid dysfunction following COVID-19 vaccination, we evaluated the risks of incident thyroid dysfunction following inactivated (CoronaVac) and mRNA (BNT162b2) COVID-19 vaccines using a population-based
Carlos King Ho Wong, David Tak Wai Lui, Xi Xiong, Celine Sze Ling Chui, Francisco Tsz Tsun Lai, Xue Li, Eric Yuk Fai Wan, Ching Lung Cheung, Chi Ho Lee, Yu Cho Woo, Ivan Chi Ho Au, Matthew Shing Hin Chung, Franco Wing Tak Cheng, Kathryn Choon Beng Tan, Ian Chi Kei Wong   +14 more
doaj   +1 more source

Vaccination Coverage Against Coronavirus Disease 2019 (COVID‐19) in Brazil's Indigenous Population

Journal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Indigenous populations in Brazil were prioritized for coronavirus disease 2019 (COVID‐19) vaccination due to their increased vulnerability. The aim of the study was to describe COVID‐19 vaccination coverage among Indigenous population across Brazilian regions and Special Indigenous Health Districts (DSEIs; acronym for Distritos Sanitários ...
Nathália Mariana Santos Sansone, Patrícia Teixeira Costa, Lucas Silva Mello, Luiz Felipe Azevedo Marques, Vinícius Santiago dos Santos, Fernando Augusto Lima Marson   +5 more
wiley   +1 more source

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2

Emerging numbers of SARS-CoV-2 infections are currently combated with a third vaccination. Considering the different vaccination regimens used for the first two vaccine doses, we addressed whether the previous vaccination influences the immune response ...
Geßner, Reinhard, Mutters, Reinier, Von Blanckenburg, Pia, Thiemer, Julia, Reiter, Rieke, Seifart, Ulf   +5 more
core   +1 more source